• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Using protein expressions to predict survival in clear cell renal carcinoma.

作者信息

Kim Hyung L, Seligson David, Liu Xueli, Janzen Nicolette, Bui Matthew H T, Yu Hong, Shi Tao, Figlin Robert A, Horvath Steve, Belldegrun Arie S

机构信息

Department of Urology, University of California School of Medicine, Los Angeles, California 90095-1738, USA.

出版信息

Clin Cancer Res. 2004 Aug 15;10(16):5464-71. doi: 10.1158/1078-0432.CCR-04-0488.

DOI:10.1158/1078-0432.CCR-04-0488
PMID:15328185
Abstract

PURPOSE

An accurate system for predicting survival for patients with solid tumors will allow for better patient selection for both established and novel therapies. We propose a staging system for clear cell variants of renal cell carcinoma (RCC) that includes molecular predictors and standard clinical predictors such as tumor-node-metastasis (TNM) stage, histological grade, and performance status (PS).

EXPERIMENTAL DESIGN

A custom tissue array was constructed using clear cell RCC from 318 patients, representing all stages of localized and metastatic RCC, and immunohistochemically stained for molecular markers Ki67, p53, gelsolin, CA9, CA12, PTEN, EpCAM, and vimentin. We present a strategy for evaluating individual candidate markers for prognostic information and integrating informative markers into a multivariate prognostic system.

RESULTS

The overall median follow-up and the median follow-up for surviving patients were 28 and 55 months, respectively. A prognostic model based primarily on molecular markers included metastasis status, p53, CA9, gelsolin, and vimentin as predictors and had high discriminatory power: its statistically validated concordance index (C-index) was found to be 0.75. A prognostic model based on a combination of clinical and molecular predictors included metastasis status, T stage, Eastern Cooperative Oncology Group PS, p53, CA9, and vimentin as predictors and had a C-index of 0.79, which was significantly higher (P < 0.05) than that of prognostic models based on grade alone (C = 0.65), TNM stage alone (C = 0.73), or the University of California Los Angeles integrated staging system (C = 0.76).

CONCLUSIONS

Protein expressions obtained using widely available technology can complement standard clinical predictors such as TNM stage, histological grade, and PS.

摘要

相似文献

1
Using protein expressions to predict survival in clear cell renal carcinoma.
Clin Cancer Res. 2004 Aug 15;10(16):5464-71. doi: 10.1158/1078-0432.CCR-04-0488.
2
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
J Urol. 2005 May;173(5):1496-501. doi: 10.1097/01.ju.0000154351.37249.f0.
3
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.局限性透明细胞肾细胞癌的分子特征预测肾切除术后无病生存期
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):894-900. doi: 10.1158/1055-9965.EPI-08-0786. Epub 2009 Feb 24.
4
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.肾细胞癌患者原发性肿瘤坏死的临床病理与分子相关性
Cancer. 2005 Jun 15;103(12):2517-25. doi: 10.1002/cncr.21127.
5
p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.p53是局限性肾细胞癌患者肾切除术后肿瘤复发和进展的独立预测指标。
J Urol. 2005 Mar;173(3):725-8. doi: 10.1097/01.ju.0000152354.08057.2a.
6
Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.肾细胞癌的组织学亚型和核分级及其对生存的影响:一项对629例患者的全国性回顾性研究。
Eur Urol. 2005 Oct;48(4):593-600. doi: 10.1016/j.eururo.2005.04.016.
7
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
8
Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.p53作为肾细胞癌组织学亚型预后标志物的价值:对原发性和转移性肿瘤组织的系统分析
Urology. 2004 Apr;63(4):651-5. doi: 10.1016/j.urology.2003.11.011.
9
Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.基于术前血清C反应蛋白和TNM分类的肾切除术治疗透明细胞肾细胞癌患者新结局预测模型的开发与外部验证:TNM-C评分
J Urol. 2009 Mar;181(3):1004-12; discussion 1012. doi: 10.1016/j.juro.2008.10.156. Epub 2009 Jan 16.
10
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.单侧散发性多灶性肾细胞癌患者与孤立性肿瘤患者在根治性肾切除术后按组织学亚型比较的长期生存率。
Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016.

引用本文的文献

1
Evaluation of the Expression of IDO and PTEN in Human Kidney Cancer.人肾癌中吲哚胺 2,3-双加氧酶(IDO)和第 10 号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)表达的评估
Curr Issues Mol Biol. 2025 May 13;47(5):359. doi: 10.3390/cimb47050359.
2
Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities.透明细胞肾细胞癌中的癌症相关成纤维细胞:功能异质性、肿瘤微环境相互作用及治疗机会
Front Immunol. 2025 Jun 4;16:1617968. doi: 10.3389/fimmu.2025.1617968. eCollection 2025.
3
Preoperative CT radiomicsbased model for predicting Ki67 expression in clear cell renal cell carcinoma patients.
基于术前CT影像组学的透明细胞肾细胞癌患者Ki67表达预测模型
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1722-1731. doi: 10.11817/j.issn.1672-7347.2024.240455.
4
Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study.基于 CT 影像组学特征和临床因素的列线图预测透明细胞肾细胞癌 Ki-67 表达和预后的研究:一项多中心研究。
Cancer Imaging. 2024 Aug 6;24(1):103. doi: 10.1186/s40644-024-00744-1.
5
The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的肿瘤免疫微环境。
Int J Mol Sci. 2023 Apr 27;24(9):7946. doi: 10.3390/ijms24097946.
6
Epstein-Barr virus infection is associated with the nuclear factor-kappa B p65 signaling pathway in renal cell carcinoma.EB 病毒感染与肾细胞癌中的核因子-κB p65 信号通路有关。
BMC Urol. 2022 Feb 7;22(1):17. doi: 10.1186/s12894-022-00964-2.
7
Identification of a Somatic Mutation-Derived Long Non-Coding RNA Signatures of Genomic Instability in Renal Cell Carcinoma.肾细胞癌中基因组不稳定的体细胞突变衍生长链非编码RNA特征的鉴定
Front Oncol. 2021 Oct 5;11:728181. doi: 10.3389/fonc.2021.728181. eCollection 2021.
8
Oncogenic potential of macrophage‑capping protein in clear cell renal cell carcinoma.巨噬细胞加帽蛋白在肾透明细胞癌中的致癌潜能。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11718. Epub 2020 Nov 25.
9
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients.透明细胞肾细胞癌患者的增殖潜能及对纳武单抗的反应
Oncoimmunology. 2020 Jun 10;9(1):1773200. doi: 10.1080/2162402X.2020.1773200.
10
Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study.肾细胞癌患者中Abl相互作用蛋白2(ABI2)与血小板/淋巴细胞比值的相关性:一项初步研究。
Int J Exp Pathol. 2020 Jun;101(3-4):87-95. doi: 10.1111/iep.12349. Epub 2020 Jun 4.